Suppr超能文献

趋化因子受体XCR1在交叉呈递树突状细胞上的选择性表达决定了与CD8 + T细胞的协同作用。

Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells.

作者信息

Dorner Brigitte G, Dorner Martin B, Zhou Xuefei, Opitz Corinna, Mora Ahmed, Güttler Steffen, Hutloff Andreas, Mages Hans W, Ranke Katja, Schaefer Michael, Jack Robert S, Henn Volker, Kroczek Richard A

机构信息

Molecular Immunology, Robert Koch-Institute, 13353 Berlin, Germany.

出版信息

Immunity. 2009 Nov 20;31(5):823-33. doi: 10.1016/j.immuni.2009.08.027. Epub 2009 Nov 12.

Abstract

The expression of the chemokine receptor XCR1 and the function of its ligand XCL1 (otherwise referred to as ATAC, lymphotactin, or SCM-1) remained elusive to date. In the present report we demonstrated that XCR1 is exclusively expressed on murine CD8(+) dendritic cells (DCs) and showed that XCL1 is a potent and highly specific chemoattractant for this DC subset. CD8(+) T cells abundantly secreted XCL1 8-36 hr after antigen recognition on CD8(+) DCs in vivo, in a period in which stable T cell-DC interactions are known to occur. Functionally, XCL1 increased the pool of antigen-specific CD8(+) T cells and their capacity to secrete IFN-gamma. Absence of XCL1 impaired the development of cytotoxicity to antigens cross-presented by CD8(+) DCs. The XCL1-XCR1 axis thus emerges as an integral component in the development of efficient cytotoxic immunity in vivo.

摘要

趋化因子受体XCR1的表达及其配体XCL1(也称为ATAC、淋巴细胞趋化因子或SCM-1)的功能至今仍不清楚。在本报告中,我们证明XCR1仅在小鼠CD8(+)树突状细胞(DCs)上表达,并表明XCL1是该DC亚群的一种强效且高度特异性的趋化因子。在体内,CD8(+)T细胞在识别CD8(+)DCs上的抗原后8 - 36小时大量分泌XCL1,而这正是已知会发生稳定的T细胞 - DC相互作用的时期。在功能上,XCL1增加了抗原特异性CD8(+)T细胞的数量及其分泌γ干扰素的能力。缺乏XCL1会损害对CD8(+)DCs交叉呈递抗原的细胞毒性的发展。因此,XCL1 - XCR1轴成为体内有效细胞毒性免疫发展的一个不可或缺的组成部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验